BIMI Holdings Price to Book Ratio 2010-2023 | BIMI
Historical price to book ratio values for BIMI Holdings (BIMI) over the last 10 years. The current price to book ratio for BIMI Holdings as of April 18, 2024 is 0.93.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| BIMI Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-04-18 | 1.34 | 0.88 | |
| 2023-09-30 | 1.57 | $1.52 | 1.03 |
| 2023-06-30 | 1.40 | $2.00 | 0.70 |
| 2023-03-31 | 0.55 | $2.14 | 0.26 |
| 2022-12-31 | 1.23 | $1.39 | 0.89 |
| 2022-09-30 | 2.84 | $2.66 | 1.07 |
| 2022-06-30 | 6.39 | $6.30 | 1.01 |
| 2022-03-31 | 13.80 | $12.93 | 1.07 |
| 2021-12-31 | 25.50 | $13.34 | 1.91 |
| 2021-09-30 | 35.95 | $53.65 | 0.67 |
| 2021-06-30 | 67.00 | $61.79 | 1.08 |
| 2021-03-31 | 87.50 | $60.78 | 1.44 |
| 2020-12-31 | 83.50 | $63.72 | 1.31 |
| 2020-09-30 | 84.00 | $63.81 | 1.32 |
| 2020-06-30 | 113.50 | $68.12 | 1.67 |
| 2020-03-31 | 124.00 | $44.66 | 2.78 |
| 2019-12-31 | 159.50 | $46.91 | 3.40 |
| 2019-09-30 | 54.50 | $60.74 | 0.90 |
| 2019-06-30 | 118.50 | $65.76 | 1.80 |
| 2019-03-31 | 310.00 | $63.80 | 4.86 |
| 2018-12-31 | 786.50 | $65.93 | 11.93 |
| 2018-09-30 | 235.00 | $157.66 | 1.49 |
| 2018-06-30 | 134.00 | $166.67 | 0.80 |
| 2018-03-31 | 71.00 | $186.84 | 0.38 |
| 2017-12-31 | 48.50 | $192.96 | 0.25 |
| 2017-09-30 | 46.50 | $191.70 | 0.24 |
| 2017-06-30 | 45.50 | $190.40 | 0.24 |
| 2017-03-31 | 55.00 | $188.32 | 0.29 |
| 2016-12-31 | 43.26 | $188.80 | 0.23 |
| 2016-09-30 | 57.50 | $213.43 | 0.27 |
| 2016-06-30 | 37.45 | $220.19 | 0.17 |
| 2016-03-31 | 37.05 | $229.13 | 0.16 |
| 2015-12-31 | 36.50 | $231.78 | 0.16 |
| 2015-09-30 | 61.50 | $242.54 | 0.25 |
| 2015-06-30 | 77.50 | $253.33 | 0.31 |
| 2015-03-31 | 87.50 | $275.31 | 0.32 |
| 2014-12-31 | 79.50 | $273.94 | 0.29 |
| 2014-09-30 | 140.13 | $277.67 | 0.50 |
| 2014-06-30 | 132.50 | $275.86 | 0.48 |
| 2014-03-31 | 80.00 | $280.86 | 0.28 |
| 2013-12-31 | 79.50 | $283.54 | 0.28 |
| 2013-09-30 | 94.00 | $289.20 | 0.33 |
| 2013-06-30 | 31.95 | $289.15 | 0.11 |
| 2013-03-31 | 41.50 | $284.02 | 0.15 |
| 2012-12-31 | 50.86 | $279.83 | 0.18 |
| 2012-09-30 | 34.55 | $278.13 | 0.12 |
| 2012-06-30 | 57.50 | $278.82 | 0.21 |
| 2012-03-31 | 47.00 | $278.40 | 0.17 |
| 2011-12-31 | 33.30 | $277.06 | 0.12 |
| 2011-09-30 | 38.05 | 0.00 | |
| 2011-06-30 | 82.78 | 0.00 | |
| 2011-03-31 | 163.01 | 0.00 | |
| 2010-12-31 | 250.53 | 0.00 | |
| 2010-09-30 | 325.00 | 0.00 | |
| 2010-06-30 | 318.75 | 0.00 | |
| 2010-03-31 | 500.00 | 0.00 | |
| 2009-12-31 | 525.00 | 0.00 | |
| 2009-09-30 | 575.00 | 0.00 | |
| 2009-06-30 | 318.75 | 0.00 | |
| 2009-03-31 | 82.50 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.016B | $0.012B |
| BIMI Holdings Inc. is a healthcare products and services provider, offering a broad range of healthcare products and related services principally in the U.S. and Asia. BIMI Holdings Inc., formerly known as BIMI International Medical Inc., is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $118.437B | 15.37 |
| Cencora (COR) | United States | $47.600B | 19.00 |
| ICON (ICLR) | Ireland | $24.090B | 23.76 |
| DiDi Global (DIDIY) | China | $22.541B | 0.00 |
| Avantor (AVTR) | United States | $16.537B | 22.78 |
| CochLear (CHEOY) | $13.442B | 0.00 | |
| Viatris (VTRS) | United States | $13.316B | 3.80 |
| Revvity (RVTY) | United States | $12.420B | 21.62 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.852B | 21.60 |
| Medpace Holdings (MEDP) | United States | $11.849B | 43.07 |
| Natera (NTRA) | United States | $10.908B | 0.00 |
| Solventum (SOLV) | United States | $10.653B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.029B | 19.34 |
| Doximity (DOCS) | United States | $4.699B | 34.99 |
| Organon (OGN) | United States | $4.568B | 4.42 |
| Progyny (PGNY) | United States | $3.148B | 52.82 |
| Surgery Partners (SGRY) | United States | $3.098B | 28.79 |
| Sotera Health (SHC) | United States | $3.043B | 14.93 |
| Life Times (LTH) | United States | $2.713B | 29.98 |
| GoodRx Holdings (GDRX) | United States | $2.567B | 130.00 |
| Premier (PINC) | United States | $2.473B | 9.05 |
| Teladoc Health (TDOC) | United States | $2.225B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.137B | 6.91 |
| Agilon Health (AGL) | United States | $2.052B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.758B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.432B | 0.00 | |
| Agiliti (AGTI) | United States | $1.365B | 22.29 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.935B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.590B | 3.89 |
| Auna S.A (AUNA) | Luxembourg | $0.554B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.510B | 46.18 |
| MultiPlan (MPLN) | United States | $0.467B | 0.00 |
| CareDx (CDNA) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.409B | 0.00 |
| LifeMD (LFMD) | United States | $0.398B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 56.00 |
| Sera Prognostics (SERA) | United States | $0.314B | 0.00 |
| ModivCare (MODV) | United States | $0.295B | 3.91 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.240B | 0.00 |
| Sharecare (SHCR) | United States | $0.237B | 0.00 |
| Biodesix (BDSX) | United States | $0.117B | 0.00 |
| So-Young (SY) | China | $0.116B | 39.00 |
| Oncology Institute (TOI) | United States | $0.087B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |